Chicago Atlantic BDC, Inc. Reports First Quarter 2025 Financial Results and Announces Cash Dividend of $0.34 per Share
NEW YORK, May 14, 2025 ( GLOBE NEWSWIRE ) -- Chicago Atlantic BDC, Inc. ( "LIEN" or the "Company" ) ( NASDAQ: LIEN ) , a specialty finance company that has elected to be regulated as a business development company, today announced its financial results for the first quarter ended March 31, 2025.
Construction begins on New York's largest solar energy project
ELBA, N.Y., May 14, 2025 ( GLOBE NEWSWIRE ) -- Greenbacker Renewable Energy Company LLC ( "Greenbacker" ) , an energy transition-focused investment manager and independent power producer, today announced the start of major construction activities on its Cider Solar Farm ( "Cider" ) in Genesee ...
atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates
With clinical momentum across its pipeline, atai strengthens its position as a leader in potentially transformative psychedelic mental health treatments ...
Cellebrite Announces First-Quarter 2025 Results
First-Quarter 2025 revenue of $107.5 million grew 20% primarily due to 21% growth in subscription revenue ...
Mesa Air Group Reports Fourth Quarter and Fiscal Full-Year 2024 Results
PHOENIX, May 14, 2025 ( GLOBE NEWSWIRE ) -- Mesa Air Group, Inc. ( NASDAQ: MESA ) ( "Mesa" or the "Company" ) today reported fourth quarter and fiscal full-year 2024 financial and operating results.
LeddarTech Reports Second Quarter 2025 Financial Results
QUEBEC CITY, Canada, May 14, 2025 ( GLOBE NEWSWIRE ) -- LeddarTech® Holdings Inc. ( "LeddarTech" or the "Company" ) ( Nasdaq: LDTC ) , an AI-powered software company recognized for its innovation in advanced driver assistance systems ( ADAS ) and autonomous driving ( AD ) , today provided a ...
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2025 Financial Results
Reported positive initial data from the Heart-2 Phase 1b clinical trial of VERVE-102 demonstrating dose-dependent decreases in blood LDL-C and ...
Ocular Therapeutix™ to Participate in Upcoming Investor Conferences
BEDFORD, Mass., May 14, 2025 ( GLOBE NEWSWIRE ) -- Ocular Therapeutix, Inc. ( NASDAQ: OCUL, "Ocular" ) , a fully-integrated biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming investor conferences in the second half of May ...










